Onza Entertainment has sold of a minority stake to Garbo Produzioni
Onza Entertainment, S.L.U. has sold a minority stake to Garbo Produzioni. With this transaction, Onza seeks to strengthen its growth in Europe, Latin America and other markets through joint content development with Garbo.
Onza Entertainment is dedicated to the production and distribution of fiction and entertainment audiovisual content and operates mainly in Spain, with a growing presence in Latin America and the USA. Its productions include the series El Ministerio del Tiempo (most awarded series with four seasons on TVE), Parot (MIPTV freshest fiction series of the year award, produced for Viacom and Amazon) and Pequeñas Coincidencias (First series produced in Spain for Amazon Prime Video).
Garbo Produzioni is an Italian audiovisual production company founded by one of the branches of the Bulgari family in 2017.
Oaklins’ team in Spain advised the shareholders of Onza on all aspects of the execution, negotiation and closing of the transaction.
Talk to the deal team
Related deals
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Learn moreFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
Learn moreBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn more